In breast cancer-associated fibroblasts, the GPER agonist G1 induced CYP19A1 gene expression and increased E2 production via the GPER/EGFR/ERK pathway which in turn promoted proliferation and cell-cycle progression [104]. This evidence concerns the gene CYP19A1 and breast cancer.